Domiciliary continuous positive airway pressure therapy in an underserved population: compliance and influential factors

Introduction Obstructive sleep apnea syndrome (OSAS) is an increasingly recognized global epidemic [1]. The current standard of treatment for moderate to severe OSAS is positive airway pressure (PAP) therapy [2]. However, diagnosis and treatment methods are expensive, and often unaffordable to those that are economically challenged and/or uninsured [3,4,9]. Reports in